137
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Effects of statins on oxidative stress and primed polymorphonuclear leukocytes in hyperlipidemic patients

, &
Pages 519-525 | Accepted 05 Aug 2012, Published online: 19 Sep 2012

References

  • Farah R, Shurtz-Swirski R, Dorlechter F (2010) Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients: effect of statins. Minerva Cardioangiol. 58: 175–181.
  • Istvan ES (2002) Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Am. Heart J. 144: 58: 175–181.
  • Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C (2005) Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J. Cell Mol. Med. 9: 3–10.
  • Kristal B, Shurtz-Swirski R, Chezar J, Manaster J, Levy R, Shapiro G, Weissman I, Shasha SM, Sela S (1998) Participation of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in patients with essential hypertension. Am. J. Hypertension 11: 921–928.
  • Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH (1996) Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled Annexin V. Blood 87: 1179–1187.
  • Maeda K, Yasunari K, Sato EF, Inoue M (2005) Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis 181: 87–92.
  • Marketou ME, Zacharis EA, Nikitovic D, Ganotakis ES, Parthenakis FI, Maliaraki N, Vardas PE (2006) Early effects of Simvastatin versus Atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology 57: 211–218.
  • Mazor R, Shurtz-Swirski R, Farah R, Kristal B, Shapiro G, Dorlechter F, Cohen-Mazor M, Meilin E, Tamara S, Sela S (2008) Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis 197: 937–943.
  • McCall CE, DeChatelet LR, Cooper MR, Shannon C (1973) Human toxic neutrophils. Metabolic characteristics. J. Infect. Dis. 127: 26–33.
  • Sela S, Shurtz-Swirski R, Awad J, Shapiro G, Nasser L, Shasha SM, Kristal B (2002) The involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in cigarette smokers. IMAJ 4: 1015–1019.
  • Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B (2005) The primed peripheral polymorphonuclear leukocyte - a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J. Am. Soc. Nephrol. 16: 2431–2438.
  • Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, Kristal B (2001) Involvement of polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetes. Diabetes Care 24: 104–110.
  • Sugano R, Matsuoka H, Haramaki N, Umei H, Murase E, Fukami K, Iida S, Ikeda H, Imaizumi T (2005) Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies. Arterioscler. Thromb. Vasc. Biol. 25: 1262–1267.
  • Swain SD, Rohn TT, Quinn MT (2002) Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox. Signal 4: 69–83.
  • Tycinska AM, Janica J, Mroczko B, Musial WJ, Sawicki R, Sobkowicz B, Kaminski K, Lebkowska U, Szmitkowski M (2011) Hypotensive effect of Atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction. Arch. Med. Sci. 7: 955–962.
  • Vervoort G, Willems HL, Werzels JF (2002) Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol. Dial. Transplant. 17: 1909–1913.
  • Yoon JW, Pahl MV, Vaziri ND (2007) Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int. 71: 167–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.